ArticlePloS one2013

Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing.

Lucile Boursault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.